| (1) The committee shall include medical and nursing
personnel with maternal-fetal knowledge and expertise, ethicists,
genetic counselors, and non-medical patient advocates, as appropriate
for the proposed study.
(2) The chair of the committee shall have an independent
objective view of the proposed intervention.
(3) The members of the committee may or may not be
directly involved with the CEFDT, but shall not be directly involved
in the proposed innovation.
(4) The committee decisions shall be independent and
without conflict of interest, either due to direct care of the patient
or by affiliation or financial gain.
(5) Documentation of in-depth discussions and actions
implemented will be maintained by the CEFDT.
(6) All non-standard fetal interventions shall have
formal approval by the committee prior to the intervention.
(7) The committee has the final authority to approve
or disapprove the innovative intervention.
(q) The CEFDT shall provide a monthly multidisciplinary
conference, involving CEFDT medical staff, nurses, ethicists, and
ancillary staff, to discuss the options for prenatal and postnatal
management of fetal anomalies and other conditions. Emergent fetal
interventions performed prior to the conference will be discussed
at the next monthly meeting after the procedure. The facility shall
maintain documentation of meetings, in depth discussion of the options,
and plan for management for all fetal therapy patients.